F Pavesi
University of Pavia
23 Papers
197 Citations
F Pavesi is an academic researcher from University of Pavia. The author has contributed to research in topics: CA 15-3 & Multiple myeloma. The author has an hindex of 8, co-authored 23 publications.
Chat about Author
Papers
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy.
Giampaolo Merlini,Giuseppe Attardo Parrinello,Lino Piccinini,Francesca Crema,M. L. Fiorentini,Alberto Riccardi,F Pavesi,Francesco Novazzi,Vittorio Silingardi,Edoardo Ascari +9 more
TL;DR: Clodronate provided a significant reduction in severe bone pain as well as in the incidence of new osteolytic lesions and pathological fractures in patients treated with chemotherapy only, and contributes significantly in controlling the progression of myeloma bone disease.
70
Effects of a New Aminodiphosphonate (Aminohydroxybutylidene Diphosphonate) in Patients With Osteolytic Lesions From Metastases and Myelomatosis: Comparison With Dichloromethylene Diphosphonate
Giuseppe Attardo-Parrinello,Giampaolo Merlini,F Pavesi,Francesca Crema,M. L. Fiorentini,Edoardo Ascari +5 more
TL;DR: The effectiveness and lack of side effects render aminohydroxybutylidene diphosphonate an attractive treatment for malignant bone resorption.
47
Detection of malignant pleural effusions by tumor marker evaluation
TL;DR: Because of their high specificity, these two parameters are a useful tool and can be routinely measured to evaluate pleural effusions of dubious origin, even if CEA and beta HCG cannot, on [corrected] their own, define the primary malignancy.
23
Detection and identification of monoclonal components: immunoelectrophoresis on agarose gel and immunofixation on cellulose acetate compared.
TL;DR: Immunofixation may be adopted as a first-step method for easier cases, but it should be supported by immunoelectrophoresis for difficult cases, such as when there is an uncertain presence of monoclonal components at screening electrophoresIS or presence of more and (or) small bands of monOClonal component.
18
Circulating CA 549 and Other Associated Antigens in Breast Cancer Patients
F Pavesi,M Lotzniker,Mariuccia Scarabelli,Elena Mauro,Gianluca Visconti,Elena Nicolato,Remigio Moratti +6 more
TL;DR: From the data obtained, the more defined cut-off and the good specificity, it is suggested that CA 549 be routinely determined in the follow-up of the disease.
16